VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions

Hypertension

Interventions

DRUG

valsartan

DRUG

irbesartan

Trial Locations (2)

Investigative Centers

Novartis Pharmaceuticals, Basel